Last reviewed · How we verify
NCT05489978
Effectiveness of a Cervical Cancer Stigma Reduction Intervention Program on Cancer Stigma Score and Cervical Cancer Screening Uptake in Nepal
NA trial testing "Cervical Cancer Stigma Reduction Intervention" in Cervical Cancer in 310 participants. Completed in 15 February 2023.
15 December 2022
Quick facts
| Lead sponsor | Kathmandu University School of Medical Sciences |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 310 |
| Start date | 15 June 2022 |
| Primary completion | 15 December 2022 |
| Estimated completion | 15 February 2023 |
| Sites | 1 location across Nepal |
Drugs / interventions tested
- "Cervical Cancer Stigma Reduction Intervention"
Conditions studied
- Cervical Cancer — all drugs for Cervical Cancer →
- Stigma — all drugs for Stigma →
- Screening — all drugs for Screening →
Sponsor
Kathmandu University School of Medical Sciences
Who can join
Adults 30 to 60, female only, with Cervical Cancer or Stigma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It is an interventional study to assess the effectiveness of the cervical cancer stigma reduction intervention on cancer stigma score and cervical cancer screening uptake in Nepal
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05489978
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cervical Cancer
Currently open trials in the same condition.
- NCT07276360 — Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda · Phase 2 · recruiting
- NCT05570422 — A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 · Phase 1 · recruiting
- NCT07225530 — Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) · NA · recruiting
- NCT07209917 — Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India · NA · recruiting
- NCT07256236 — SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer · Phase 2 · recruiting
Other Kathmandu University School of Medical Sciences trials
Trials by the same sponsor.
- NCT07506980 — Nurse Led Intervention on Self Care Adherence and Quality of Life · NA · not yet recruiting
- NCT07089290 — A Study Protocol to Assess the Effectiveness of Nurse-Led Telehealth Intervention for Hypertension Control in Nepal · NA · not yet recruiting
- NCT07002606 — The General Objective of This Study is to Monitor, Assess, and Prevent the Potential Medication Errors Among Inpatients · not yet recruiting
- NCT06444100 — Predictors of Child Abuse Among School Going Children and the Impact of Structural Training on Child Abuse Among School · NA · not yet recruiting
- NCT06435598 — Tittle: Effect of Video-Based Health Education Intervention on Insulin Therapy Among Adults With Diabetes Mellitus in Dh · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05489978 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kathmandu University School of Medical Sciences
- Last refreshed: 15 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05489978.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing